... are leveraging Fuzionaire Dx's radiolabeling platform to study and treat traditionally challenging diseases in areas such as neurology and oncology. ... read more
Fuzionaire Diagnostics Announces Disease-Agnostic Platform to Radiolabel Any Molecule for ...
Fuzionaire Diagnostics Announces Disease-Agnostic Platform to Radiolabel Any Molecule for …